Literature DB >> 32214198

MicroRNA-200 family governs ovarian inclusion cyst formation and mode of ovarian cancer spread.

Pui-Wah Choi1,2, Wai Wing So2, Junzheng Yang1, Shubai Liu1, Ka Kui Tong2, Kin Ming Kwan2,3,4, Jamie S-L Kwok5, Stephen K W Tsui5, Shu-Kay Ng6, Karen H Hales7, Dale B Hales7,8, William R Welch9, Christopher P Crum9, Wing-Ping Fong10, Ross S Berkowitz1, Shu-Wing Ng1,11.   

Abstract

Epidemiologic and histopathologic findings and the laying hen model support the long-standing incessant ovulation hypothesis and cortical inclusion cyst involvement in sporadic ovarian cancer development. MicroRNA-200 (miR-200) family is highly expressed in ovarian cancer. Herewith, we show that ovarian surface epithelial (OSE) cells with ectopic miR-200 expression formed stabilized cysts in three-dimensional (3D) organotypic culture with E-cadherin fragment expression and steroid hormone pathway activation, whereas ovarian cancer 3D cultures with miR-200 knockdown showed elevated TGF-β expression, mitotic spindle disorientation, increased lumenization, disruption of ROCK-mediated myosin II phosphorylation, and SRC signaling, which led to histotype-dependent loss of collective movement in tumor spread. Gene expression profiling revealed that epithelial-mesenchymal transition and hypoxia were the top enriched gene sets regulated by miR-200 in both OSE and ovarian cancer cells. The molecular changes uncovered by the in vitro studies were verified in both human and laying hen ovarian cysts and tumor specimens. As miR-200 is also essential for ovulation, our results of estrogen pathway activation in miR-200-expressing OSE cells add another intriguing link between incessant ovulation and ovarian carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32214198     DOI: 10.1038/s41388-020-1264-x

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  54 in total

1.  A pilot study of ovarian cancer chemoprevention using medroxyprogesterone acetate in an avian model of spontaneous ovarian carcinogenesis.

Authors:  Mack N Barnes; Wallace D Berry; J Michael J Straughn; Tyler O Kirby; Charles A Leath; Warner K Huh; William E Grizzle; Edward E Partridge
Journal:  Gynecol Oncol       Date:  2002-10       Impact factor: 5.482

2.  The restricted ovulator chicken: a unique animal model for investigating the etiology of ovarian cancer.

Authors:  James R Giles; Robert G Elkin; Lindsey S Trevino; Mary E Urick; Ramesh Ramachandran; Patricia A Johnson
Journal:  Int J Gynecol Cancer       Date:  2010-07       Impact factor: 3.437

3.  Incessant ovulation--a factor in ovarian neoplasia?

Authors:  M F Fathalla
Journal:  Lancet       Date:  1971-07-17       Impact factor: 79.321

4.  Multiple births and risk of epithelial ovarian cancer.

Authors:  D C Whiteman; M F Murphy; L S Cook; D W Cramer; P Hartge; P A Marchbanks; P C Nasca; R B Ness; D M Purdie; H A Risch
Journal:  J Natl Cancer Inst       Date:  2000-07-19       Impact factor: 13.506

Review 5.  Pathology of ovarian cancer precursors.

Authors:  R E Scully
Journal:  J Cell Biochem Suppl       Date:  1995

6.  Ovarian cancer screening and early detection in the general population.

Authors:  Jose A Rauh-Hain; Thomas C Krivak; Marcela G Del Carmen; Alexander B Olawaiye
Journal:  Rev Obstet Gynecol       Date:  2011

7.  Biomarkers and endosalpingiosis in the ovarian and tubal microenvironment of women at high-risk for pelvic serous carcinoma.

Authors:  Christine Gruessner; Angelika Gruessner; Katherine Glaser; Nisreen Abushahin; Cynthia Laughren; Wenxin Zheng; Setsuko K Chambers
Journal:  Am J Cancer Res       Date:  2014-01-15       Impact factor: 6.166

8.  Determinants of ovarian cancer risk. I. Reproductive experiences and family history.

Authors:  D W Cramer; G B Hutchison; W R Welch; R E Scully; K J Ryan
Journal:  J Natl Cancer Inst       Date:  1983-10       Impact factor: 13.506

9.  The hen as a model of ovarian cancer.

Authors:  Patricia A Johnson; James R Giles
Journal:  Nat Rev Cancer       Date:  2013-05-16       Impact factor: 60.716

10.  E-cadherin expression in ovarian cancer in the laying hen, Gallus domesticus, compared to human ovarian cancer.

Authors:  Kristine Ansenberger; Yan Zhuge; Jo Ann J Lagman; Cassandra Richards; Animesh Barua; Janice M Bahr; Dale Buchanan Hales
Journal:  Gynecol Oncol       Date:  2009-03-24       Impact factor: 5.482

View more
  6 in total

Review 1.  The Dysregulation of MicroRNAs in the Development of Cervical Pre-Cancer-An Update.

Authors:  Pui-Wah Choi; Tin Lun Liu; Chun Wai Wong; Sze Kei Liu; Yick-Liang Lum; Wai-Kit Ming
Journal:  Int J Mol Sci       Date:  2022-06-27       Impact factor: 6.208

Review 2.  Revisiting the miR-200 Family: A Clan of Five Siblings with Essential Roles in Development and Disease.

Authors:  Vignesh Sundararajan; Ulrike C Burk; Karolina Bajdak-Rusinek
Journal:  Biomolecules       Date:  2022-06-03

3.  microRNA-1271-5p/TIAM1 suppresses the progression of ovarian cancer through inactivating Notch signaling pathway.

Authors:  Feng-Juan Han; Jia Li; Ying Shen; Ying Guo; Yi-Chao Liu; Yang Yu; Jia-Yue Xu; Shao-Xuan Liu; Yan-Hong Wang
Journal:  J Ovarian Res       Date:  2020-09-18       Impact factor: 4.234

4.  Extracellular Vesicles from Uterine Aspirates Represent a Promising Source for Screening Markers of Gynecologic Cancers.

Authors:  Gleb O Skryabin; Andrey V Komelkov; Kirill I Zhordania; Dmitry V Bagrov; Svetlana V Vinokurova; Sergey A Galetsky; Nadezhda V Elkina; Darya A Denisova; Adel D Enikeev; Elena M Tchevkina
Journal:  Cells       Date:  2022-03-22       Impact factor: 6.600

5.  Long non-coding RNA SNHG10 upregulates BIN1 to suppress the tumorigenesis and epithelial-mesenchymal transition of epithelial ovarian cancer via sponging miR-200a-3p.

Authors:  Wei Lv; Yunlong Jia; Jiali Wang; Yuqing Duan; Xuexiao Wang; Tianxu Liu; Shuwei Hao; Lihua Liu
Journal:  Cell Death Discov       Date:  2022-02-11

Review 6.  A Review of Principal Studies on the Development and Treatment of Epithelial Ovarian Cancer in the Laying Hen Gallus gallus.

Authors:  Purab Pal; Kara Nicole Starkweather; Karen Held Hales; Dale Buchanan Hales
Journal:  Comp Med       Date:  2021-07-29       Impact factor: 0.982

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.